Madrigal Pharmaceuticals (MDGL) Other Gross PP&E Adjustments (2019 - 2025)
Madrigal Pharmaceuticals (MDGL) has disclosed Other Gross PP&E Adjustments for 12 consecutive years, with -$26.9 million as the latest value for Q4 2025.
- Quarterly Other Gross PP&E Adjustments fell 43.41% to -$26.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$26.9 million through Dec 2025, down 43.41% year-over-year, with the annual reading at -$26.9 million for FY2025, 43.41% down from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 was -$26.9 million at Madrigal Pharmaceuticals, down from -$5.4 million in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was -$411000.0 in Q2 2023, with the low at -$35.7 million in Q4 2023.
- Average Other Gross PP&E Adjustments over 5 years is -$8.1 million, with a median of -$1.7 million recorded in 2023.
- The sharpest move saw Other Gross PP&E Adjustments surged 61.12% in 2023, then plummeted 302.61% in 2025.
- Over 5 years, Other Gross PP&E Adjustments stood at -$25.1 million in 2021, then fell by 10.73% to -$27.8 million in 2022, then dropped by 28.25% to -$35.7 million in 2023, then surged by 47.48% to -$18.7 million in 2024, then tumbled by 43.41% to -$26.9 million in 2025.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at -$26.9 million, -$5.4 million, and -$5.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.